# Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

> **NCT06598176** · NA · RECRUITING · sponsor: **Universiteit Antwerpen** · enrollment: 100 (estimated)

## Conditions studied

- Uterine Cervical Neoplasm
- Uterine Cervical Dysplasia
- Human Papilloma Virus
- HPV-Related Cervical Carcinoma

## Interventions

- **DEVICE:** Colli-Pee 20mL device with UCM
- **DEVICE:** Evalyn Brush

## Key facts

- **NCT ID:** NCT06598176
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-28
- **Primary completion:** 2027-02-28
- **Final completion:** 2037-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06598176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06598176, "Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06598176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*